Diseases caused by chlamydiae

AB1_CHLAMY_OTHER

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — A74 Hospital discharge: ICD-9 — 07[6] Hospital discharge: excluded ICD-9 — 0760A Cause of death: ICD-10 — A74 Cause of death: ICD-9 — 07[6] Cause of death: excluded ICD-9 — 0760A 2 out of 7 registries used, show all original rules.	404
4. Check minimum number of events None	404
5. Include endpoints None	404
6. Filter based on genotype QC (FinnGen only)	404

Control definitions (FinnGen only)

Control exclude: AB1_OTHER_CHLAMYDIAE

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF12

NAME	AB1_CHLAMY_OTHER
CONTROL_EXCLUDE	AB1_OTHER_CHLAMYDIAE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	A74
HD_ICD_9	07[6]
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL	0760A
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	A74
COD_ICD_9	07[6]
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL	0760A
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Diseases caused by chlamydiae based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	404	356	48
Unadjusted period prevalence (%)	0.11	0.12	0.02
Median age at first event (years)	24.51	22.76	37.47

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

No data available

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3021589) Normoblasts [#/volume] in Blood

201

1453

1.76

7.21

9.8

7.9

0.0

e9/l

1.12

169

1209

(3030467) Casts [#/volume] in Urine by Automated count

115

710

1.87

6.94

3.5

2.5

0.5

0.4

e6/l

0.15

522

(3002582) Erythrocytes [#/volume] in Urine

124

787

1.83

6.84

3.5

2.6

22.5

149.9

e6/l

0.99

599

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

496

1.90

6.03

2.1

2.0

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

279

2.12

5.75

2.0

1.8

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

3.51

5.65

1.3

1.1

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

138

959

1.67

5.31

4.5

2.7

—

(40758558) Short blood count panel - Blood

124

844

1.68

5.14

5.5

6.7

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

2.87

5.13

1.4

1.1

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

125

857

1.66

5.03

2.0

124.2

139.8

u/l

0.43

119

819

(3000850) Epithelial cells [#/volume] in Urine

541

1.78

4.98

3.0

2.1

7.0

8.4

e6/l

0.32

483

(36304419) Bacteria [Presence] in Urine

108

718

1.69

4.86

3.6

2.4

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

647

1.70

4.74

1.8

1.7

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

205

1601

1.57

4.73

7.4

5.4

9.1

9.4

umol/l

0.46

198

1532

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

228

2.10

4.72

1.8

1.7

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

408

1.83

4.65

2.7

2.3

1.3

1.0

e6/l

0.23

219

(3045414) Leukocytes [Presence] in Urine

141

2.30

4.24

1.9

1.6

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

455

1.74

4.11

1.9

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

376

1.80

4.11

2.8

2.4

1.7

3.9

e6/l

1.74

190

(3018095) Leukocytes [#/volume] in Urine

135

987

1.55

4.02

4.4

2.9

29.5

64.3

e6/l

1.43

665

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

518

1.68

3.92

2.1

2.7

738.1

481.4

ng/l

0.31

428

(3045424) Erythrocytes [Presence] in Urine

3.04

3.89

1.8

1.6

—

(3021601) Nitrite [Presence] in Urine by Test strip

197

1571

1.50

3.86

5.5

4.1

0.0

estimate

0.50

278

(3035350) Ketones [Presence] in Urine by Test strip

196

1564

1.49

3.82

3.9

2.9

0.0

estimate

0.00

272

(3011397) Hemoglobin [Presence] in Urine by Test strip

675

1.60

3.75

3.5

3.0

—

(3009261) Glucose [Presence] in Urine by Test strip

198

1589

1.48

3.72

3.9

2.9

0.0

estimate

0.80

269

(3012501) Base excess in Blood by calculation

3.12

3.56

2.0

1.5

2.7

mmol/l

—

(3027315) Oxygen [Partial pressure] in Blood

3.12

3.56

2.0

9.2

9.1

kpa

0.05

(3013290) Carbon dioxide [Partial pressure] in Blood

3.12

3.56

2.0

4.7

5.1

kpa

2.02

(3028433) Virus identified in Specimen by Culture

7.10

3.37

1.9

1.1

—

(3022145) Colonoscopy Study observation

367

1.71

3.34

1.6

1.3

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

159

2.03

3.19

2.0

1.7

685.8

2559.6

u/l

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

284

2488

1.48

3.16

9.6

6.6

77.4

74.9

u/l

0.54

270

2357

(3018418) pH of Serum or Plasma

109

800

1.50

3.09

4.6

3.4

7.4

0.17

137

(3019832) Treponema pallidum Ab [Presence] in Serum

314

1.71

3.00

1.9

1.6

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

366

3406

1.79

3.00

14.2

10.3

139.6

139.8

mmol/l

0.64

358

3318

(3013826) Glucose [Moles/volume] in Serum or Plasma

199

1647

1.41

2.94

5.7

3.7

6.5

6.4

mmol/l

0.19

189

1543

(3026782) Osmolality of Urine

505

1.57

2.91

2.8

2.2

525.6

539.4

mosm/kgh2o

0.18

441

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

2.65

2.90

1.3

1.1

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

5.46

2.88

1.4

1.3

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

130

2.07

2.88

7.6

7.4

25.0

25.1

mmol/l

0.04

130

(3023103) Potassium [Moles/volume] in Serum or Plasma

366

3419

1.75

2.78

14.3

10.4

3.9

mmol/l

0.01

356

3326

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

312

2816

1.47

2.72

4.7

4.3

14.5

14.3

pmol/l

0.90

296

2655

(3029937) Albumin [Presence] in Urine by Test strip

107

803

1.45

2.68

3.9

3.2

0.0

estimate

0.50

277

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

173

1415

1.39

2.66

2.3

76.5

76.3

nmol/l

0.02

162

1308

(3022806) Fractional oxyhemoglobin in Capillary blood

3.66

2.59

1.8

1.5

89.3

92.0

—

(3020779) Urea [Moles/volume] in Serum or Plasma

165

1.88

2.57

14.1

7.8

7.6

7.7

mmol/l

0.03

160

(40761535) Cells panel - Urine sediment

210

1.78

2.57

5.0

3.2

—

(40768443) Skin Pathology biopsy report

129

2.00

2.56

1.1

1.2

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

348

3225

1.57

2.54

12.4

8.9

89.9

88.7

ml/min/173m2

0.54

296

2648

(3044640) Blood type and Crossmatch panel - Blood

120

932

1.41

2.47

2.5

2.0

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

483

1.52

2.43

2.2

1.6

1.5

1.4

0.75

439

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

245

1.70

2.42

2.7

—

(40768441) Liver Pathology biopsy report

3.69

2.37

3.1

1.2

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

574

1.47

2.32

1.6

439.1

24023875.4

pmol/l

0.78

512

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

354

1.57

2.30

7.1

2.1

5.6

5.0

umol/l

0.20

300

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

682

1.43

2.27

2.6

2.0

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

449

1.51

2.23

1.3

1.4

32.4

33.0

iu/l

0.05

397

(42870588) Differential panel, method unspecified - Blood

131

1052

1.36

2.17

7.1

5.8

—

(3011648) Oxygen content in Venous blood

3.73

2.16

1.6

2.2

8.6

12.0

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

101

779

1.40

2.14

2.0

1.7

1.5

0.8

mg/l

1.49

595

(3019309) Folate [Moles/volume] in Red Blood Cells

411

1.51

2.13

1.8

1.6

1317.7

1146.8

nmol/l

0.85

318

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

132

1065

1.36

2.12

1.9

1.8

111.5

99.9

pmol/l

0.85

572

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

147

1206

1.34

2.11

7.6

4.9

1.2

mmol/l

0.06

140

1096

(3048689) Calprotectin [Mass/mass] in Stool

506

1.46

2.11

3.4

2.2

117.1

99.4

ug/g

0.29

398

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

346

3233

1.49

2.10

5.3

5.0

1.7

2.1

mu/l

0.66

328

3068

(3052851) Hemolysis interference index of Serum or Plasma

2.12

2.10

4.2

2.7

—

(3028271) Lactate [Moles/volume] in Capillary blood

2.95

2.08

1.8

1.5

1.6

mmol/l

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

364

3439

1.59

2.08

14.7

10.4

19.0

18.6

mg/l

0.07

294

2618

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

5.05

2.07

5.8

2.8

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

3.54

2.06

2.4

1.4

—

(3021960) Folate [Moles/volume] in Serum or Plasma

579

1.43

2.05

1.5

1.4

17.9

21.0

nmol/l

1.64

509

(3023368) Bacteria identified in Blood by Culture

597

1.42

2.04

4.7

3.6

—

(3003327) Ova and parasites identified in Stool by Light microscopy

141

1.82

2.02

1.5

1.8

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

143

1177

1.33

1.99

6.7

4.2

35.7

36.8

g/l

1.52

136

1112

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

105

1.95

1.99

3.1

1.7

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

504

1.45

1.97

1.8

1.5

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

351

1.52

1.95

3.4

2.1

29.9

29.7

0.06

342

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

170

1438

1.31

1.95

4.5

3.6

—

(1616796) Gas panel - Central venous blood

2.48

1.94

1.3

1.9

—

(3007853) Bacteria identified in Skin by Aerobe culture

346

1.51

1.87

1.6

1.5

—

(3006315) Basophils [#/volume] in Blood

194

1681

1.30

1.83

7.4

5.7

0.0

e9/l

0.24

172

1495

(3025130) Human papilloma virus identified in Specimen

2.00

1.82

1.8

1.9

—

(3026008) Bacteria identified in Urine by Culture

100

790

1.35

1.81

2.9

2.3

—

(4034850)

102

1.91

1.79

5.1

7.8

—

(40760892) CBC W Ordered Manual Differential panel - Blood

107

856

1.34

1.79

4.8

4.2

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

190

1646

1.29

1.78

2.9

2.7

97.1

78.3

ug/l

1.21

183

1556

(3001604) Monocytes [#/volume] in Blood

193

1676

1.29

1.77

7.4

5.7

0.6

0.5

e9/l

1.21

172

1493

(3013707) Erythrocyte sedimentation rate by Westergren method

275

2503

1.31

1.75

4.5

3.8

10.4

9.9

mm/h

0.32

254

2357

(3001019) Free T4 and TSH panel - Serum or Plasma

378

0.58

1.74

1.9

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

124

1018

1.31

1.73

3.3

2.6

26.5

19.6

ng/l

0.48

478

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

2.13

1.67

1.1

1.8

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

3.60

1.62

1.0

1.4

—

(3051651) Icteric interference index of Serum or Plasma

3.60

1.62

4.4

2.3

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

3.60

1.62

1.0

1.4

—

(3037467) Urinalysis macro (dipstick) panel - Urine

240

2158

1.28

1.61

4.8

3.6

—

(3019198) Lymphocytes [#/volume] in Blood

198

1740

1.27

1.60

7.3

5.7

2.0

e9/l

0.06

180

1571

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

322

3012

1.34

1.58

4.8

4.4

38.2

38.3

mmol/mol

0.12

305

2874

(3002385) Erythrocyte distribution width [Ratio]

317

2959

1.33

1.57

16.3

12.7

13.6

13.5

0.20

312

2917

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

2.45

1.54

1.0

1.2

—

(3032080) INR in Blood by Coagulation assay

114

942

1.29

1.50

7.4

5.8

1.0

1.1

inr

0.43

297

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

138

1169

1.27

1.49

5.5

3.0

35.7

29.4

u/l

0.93

130

1123

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

2.07

1.45

1.8

1.5

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

379

3657

1.59

1.44

11.7

8.9

25.7

25.3

u/l

0.16

369

3571

(3051611) Lipemic interference index of Serum or Plasma

2.75

1.44

4.0

2.4

—

(3013115) Eosinophils [#/volume] in Blood

198

1758

1.25

1.41

7.6

6.3

0.2

e9/l

0.98

179

1575

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

157

1358

1.26

1.41

8.5

5.8

1.2

mmol/l

0.45

133

1139

(3021879) Hepatitis B virus core Ab [Presence] in Serum

241

1.50

1.38

1.4

1.3

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

387

1.39

1.37

1.7

1.5

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

2.63

1.37

4.7

1.1

—

(3012516) Albumin [Mass/volume] in Urine

674

1.31

1.37

3.7

3.0

915.4

549.5

mg/l

0.16

410

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

177

1.56

1.32

1.6

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1.91

1.30

1.9

1.6

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

2.38

1.30

1.0

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

348

0.64

1.27

1.3

1.2

295.8

158.5

iu/ml

—

159

(4281824)

2.02

1.24

1.0

1.1

—

(3020682) Albumin/Creatinine [Ratio] in Urine

703

1.28

1.22

4.2

3.6

11.1

5.8

mg/mmol

0.26

423

(3019150) Specific gravity of Urine by Refractometry

687

1.28

1.19

3.2

3.1

1.0

kg/l

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

2.33

1.19

1.2

—

(4306422)

1.96

1.18

1.1

—

(3007164) IgA [Mass/volume] in Serum or Plasma

736

1.27

1.15

1.8

1.4

2.0

2.1

g/l

0.27

496

(3044889) 12 lead EKG panel

242

2225

1.22

1.15

2.9

—

(3045142) Bone marrow Pathology biopsy report

2.52

1.15

1.6

1.5

—

(4024509)

2.52

1.15

1.2

—

(3009508) Creatinine [Moles/volume] in Urine

783

1.26

1.15

5.0

2.7

7.7

mmol/l

0.01

674

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

243

1.44

1.14

2.2

2.0

66.5

78.9

ml/min/173m2

0.85

(3025941) Bacteria identified in Stool by Culture

202

1.47

1.11

1.2

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

501

1.31

1.11

2.8

3.0

40.8

286.5

ng/l

0.93

295

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

128

1.59

1.10

1.7

1.4

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

214

1950

1.21

1.10

10.8

9.3

4.1

3.9

e9/l

0.49

193

1733

(3021788) Differential panel - Synovial fluid

1.97

1.09

1.4

1.6

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

2.21

1.08

1.0

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

2.21

1.08

1.0

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

2.21

1.08

1.0

1.2

—

(3028707) Methadone [Presence] in Urine by Screen method

1.78

1.08

5.8

1.5

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

144

1265

1.21

1.08

3.9

2.9

—

(3022096) Basophils/100 leukocytes in Blood

170

1519

1.21

1.06

7.3

5.8

0.7

0.14

162

1421

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

2.14

1.06

1.0

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

2.14

1.06

1.0

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

2.14

1.06

1.0

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

130

1.57

1.04

1.7

1.5

—

(3003694) ABO and Rh group [Type] in Blood

101

858

1.24

1.04

1.7

1.4

—

(3024928) Oxygen saturation in Venous blood

1.98

1.04

8.1

2.3

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

340

3255

1.28

1.03

4.1

3.7

5.8

5.7

mmol/l

0.63

318

3085

(3020961) Endomysium IgA Ab [Titer] in Serum

223

1.42

1.02

1.1

—

106.0

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

233

1.41

0.99

2.2

1.7

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

0.00

0.97

0.0

1.1

—

6.7

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

0.00

0.97

0.0

1.0

—

(3002256) Pathology report gross observation

466

1.29

0.96

1.2

—

(44790048)

0.00

0.95

0.0

1.4

—

(44790047)

0.00

0.95

0.0

1.4

—

(44806118)

0.00

0.95

0.0

1.4

—

(44790049)

0.00

0.95

0.0

1.4

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

1.78

0.95

1.2

1.5

—

29.3

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

2.24

0.94

2.5

2.2

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

356

3439

1.30

0.92

4.0

3.9

4.9

5.0

mmol/l

0.23

344

3300

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

211

1.40

0.91

4.1

3.5

84.8

72.0

ng/l

0.20

191

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

1.77

0.91

1.0

1.1

—

(3014051) Protein [Presence] in Urine by Test strip

1.77

0.91

1.9

1.6

—

(3014007) Fractional oxyhemoglobin in Arterial blood

111

1.55

0.89

18.5

10.0

92.8

93.2

0.11

111

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

844

1.21

0.89

1.7

1.5

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

1.88

0.87

1.5

1.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1.88

0.87

1.3

1.7

—

(40761536) Microorganisms panel - Urine sediment

239

1.37

0.87

4.7

3.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1.83

0.86

1.4

1.5

37.7

42.3

nmol/l

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1.83

0.86

1.6

1.5

—

(40761511) CBC panel - Blood by Automated count

373

3632

1.35

0.85

12.4

9.6

—

(3013512) EKG study

725

1.22

0.85

3.1

2.9

—

(3006504) Eosinophils/100 leukocytes in Blood

173

1574

1.17

0.84

7.5

5.7

2.9

2.8

0.47

167

1473

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

366

1.29

0.83

2.4

1.8

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

354

3426

1.27

0.83

4.0

3.8

1.5

mmol/l

0.52

340

3270

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

100

869

1.20

0.83

1.3

1.2

1.7

u/ml

0.30

254

(3004616) Nuclear Ab [Presence] in Serum

1.72

0.81

1.1

1.3

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

106

1.53

0.80

1.4

1.3

1.5

19.1

u/ml

—

(3017181) Myelocytes/100 leukocytes in Blood

252

1.34

0.79

4.3

0.2

1.1

—

(3023419) Bacteria identified in Sputum by Culture

0.00

0.78

0.0

3.3

—

(3004588) Protein electrophoresis panel - Serum or Plasma

140

1.45

0.78

1.7

2.1

—

(3025159) Blasts/100 leukocytes in Blood

227

1.35

0.77

4.4

4.5

0.0

0.3

—

(3008295) Osmolality of Serum or Plasma

0.00

0.76

0.0

1.5

—

284.5

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

650

1.21

0.74

2.6

2.0

3.4

2.8

mg/l

1.13

547

(3037522) Nuclear Ab [Titer] in Serum

548

1.22

0.73

1.5

1.3

530.0

556.9

titre

0.07

117

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

2.01

0.73

1.4

1.2

—

(44813793)

2.01

0.73

1.0

1.1

—

(3049717) Cytology report of Urine Cyto stain

1.60

0.72

2.1

1.9

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

240

0.70

0.72

1.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

1.93

0.71

1.0

—

(3023520) Reticulocytes [#/volume] in Blood

152

1.40

0.70

3.5

2.6

74.6

74.8

e9/l

0.01

108

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

342

3311

1.21

0.70

3.6

3.5

1.3

mmol/l

1.19

330

3157

(4268621)

1.72

0.70

2.0

2.3

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

265

2514

1.16

0.70

4.2

2.9

55.1

38.3

u/l

0.84

250

2422

(3044941) Cell count panel - Synovial fluid

1.68

0.68

1.4

—

(3002179) Metamyelocytes/100 leukocytes in Blood

232

1.32

0.68

4.2

0.0

0.8

—

(3019069) Monocytes/100 leukocytes in Blood

171

1579

1.14

0.65

8.0

5.9

8.1

0.09

166

1494

(1001926) Buprenorphine [Presence] in Urine by Screen method

129

1.41

0.64

4.7

1.4

—

(40768795) Lymph node Pathology biopsy report

1.73

0.64

1.2

—

(3021440) Promyelocytes/100 leukocytes in Blood

235

1.30

0.63

4.6

4.5

0.0

0.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1.55

0.60

1.4

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1.55

0.60

1.5

1.6

—

(3009871) Measles virus Ab [Titer] in Serum

0.00

0.59

0.0

1.9

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

238

1.28

0.58

2.2

1.7

—

(21494755) Public health laboratory ask at order entry panel

555

0.83

0.57

1.2

1.3

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1.46

0.56

1.6

2.6

—

(3037756) Immunofixation for Serum or Plasma

1.63

0.55

2.3

1.8

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

478

0.82

0.55

1.8

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

104

939

1.14

0.54

1.6

1.4

—

(3005033) Fetal Nuchal fold Thickness US

1.49

0.54

1.3

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1.49

0.54

1.3

1.4

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1.50

0.54

2.4

1.4

—

(3009542) Hematocrit [Volume Fraction] of Blood

323

3321

0.86

0.54

14.9

11.3

40.4

40.1

0.45

257

2765

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

356

3478

1.20

0.54

4.4

4.1

2.9

3.0

mmol/l

0.37

338

3316

(3024891) Influenza virus A+B Ag [Presence] in Specimen

117

1.38

0.53

1.3

1.1

—

(40768804) Tissue Pathology biopsy report

162

1508

1.12

0.53

2.3

2.0

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1.53

0.53

1.4

1.2

—

(3026493) Urate [Moles/volume] in Serum or Plasma

759

1.15

0.52

2.8

2.1

305.2

4525.3

umol/l

2.75

698

(3020891) Body temperature

1.48

0.51

1.9

3.9

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1.39

0.51

1.3

1.6

—

(3022621) pH of Urine by Test strip

189

1.29

0.51

2.0

1.9

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

101

1.40

0.50

1.6

1.3

15.1

16.0

u/l

0.08

(3030905) Polymorphonuclear cells [#/volume] in Blood

1.51

0.50

3.2

4.0

3.4

4.5

e9/l

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

1.53

0.48

4.1

4.2

32.5

30.6

mg/l

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1.53

0.48

1.6

1.2

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1.53

0.48

4.1

4.2

37.9

19.8

mg/l

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1.53

0.48

1.6

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1.50

0.48

1.4

1.3

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

155

1.31

0.47

2.3

2.7

4.8

ug/l

1.08

137

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

1.48

0.47

3.2

4.7

50.0

58.0

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

255

1.23

0.47

1.1

1.2

—

34.7

—

(36660697) Celiac disease serology panel - Serum

292

1.22

0.47

1.3

1.2

—

(3008898) HLA-B27 [Presence]

192

1.27

0.46

1.2

1.1

—

(40768797) Stomach Pathology biopsy report

462

1.17

0.45

1.3

1.2

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

846

1.13

0.44

1.8

1.7

1.5

1.4

mmol/l

0.60

743

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1.38

0.44

3.9

2.4

24.4

24.2

mmol/l

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

250

0.79

0.42

1.7

1.5

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1.41

0.42

1.0

1.3

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

287

2779

1.11

0.42

3.8

3.5

—

(3018010) Neutrophils/100 leukocytes in Blood

172

1624

1.10

0.42

7.6

5.4

56.0

56.5

0.21

167

1536

(3000494) Fungus identified in Specimen by Culture

362

1.18

0.41

1.6

1.3

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

0.00

0.41

0.0

1.3

—

5.6

—

(3006653) Thiamine [Moles/volume] in Blood

0.00

0.40

0.0

1.6

—

150.4

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

1.48

0.40

3.2

1.6

0.9

1.0

g/l

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

237

0.79

0.40

1.1

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.40

0.0

1.1

—

32.0

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

0.00

0.40

0.0

1.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

355

0.83

0.39

1.5

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1.42

0.39

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1.42

0.39

1.5

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1.42

0.39

1.5

1.4

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1.42

0.39

1.0

1.2

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1.42

0.39

1.5

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1.42

0.39

1.5

1.4

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

133

1.29

0.39

1.4

2.2

—

(40760888) Immunoglobulin light chains.free panel - Serum

1.39

0.38

5.0

4.5

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

107

1.32

0.37

1.1

1.2

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

342

0.84

0.37

4.7

3.7

34.0

32.7

0.26

250

(3012544) pH of Venous blood

198

1.23

0.37

4.6

3.5

—

(3026389) Candida sp identified in Specimen by Organism specific culture

1.36

0.37

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

1.27

0.36

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

1.43

0.35

1.0

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

1.43

0.35

1.0

1.4

—

(3000991) Gas panel - Venous blood

163

1.24

0.34

20.5

8.4

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

714

1.11

0.34

1.3

3.2

12.0

u/ml

2.20

317

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

1.37

0.34

2.0

1.4

407.0

410.0

pmol/l

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1.34

0.34

1.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

1.31

0.32

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

1.31

0.32

1.1

—

(3027008) Opiates [Presence] in Urine

166

1.22

0.30

4.4

1.4

—

(3000764) Benzodiazepines [Presence] in Urine

166

1.22

0.30

4.5

1.4

—

(3028300) Cannabinoids [Presence] in Urine

166

1.22

0.30

4.4

1.4

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

111

1.27

0.30

5.8

2.2

1.5

1.2

0.55

111

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

1.25

0.29

1.0

1.2

—

(3019060) Gas panel - Arterial blood

117

0.76

0.28

1.3

5.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1.24

0.27

1.6

1.3

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

725

1.09

0.27

1.3

14.1

25.7

iu/ml

2.46

256

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

141

1.21

0.26

1.6

1.7

—

(3003396) Base excess in Arterial blood by calculation

226

1.16

0.25

12.7

7.7

0.7

1.4

mmol/l

0.32

172

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1.27

0.24

1.5

1.2

—

(3044290) Cell count panel - Cerebral spinal fluid

1.17

0.24

1.2

1.8

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1.29

0.24

2.3

1.4

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

169

0.82

0.24

3.6

1.8

—

(3011288) Drugs identified in Urine by Screen method

106

1.23

0.23

3.3

1.6

—

(4062490)

1.32

0.23

1.2

1.3

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

1.32

0.23

1.0

—

(1002224) Polysomnography panel

210

0.85

0.22

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

1.25

0.22

1.6

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

1.22

0.22

1.6

1.3

—

(3032773) Endomysium IgG Ab [Titer] in Serum

1.22

0.22

1.0

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

107

1.22

0.22

1.1

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

1.19

0.21

1.6

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

1.19

0.21

1.8

1.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

1.19

0.21

1.6

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

1.19

0.21

1.8

1.3

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.3

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.3

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

0.00

0.21

0.0

1.0

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

0.00

0.21

0.0

1.0

—

99.2

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3016879) Cocaine [Presence] in Urine

154

1.18

0.21

4.7

1.4

—

(3034988) Calcium [Moles/volume] in Capillary blood

0.00

0.21

0.0

1.2

—

1.2

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1.24

0.21

1.5

2.0

3.7

3.8

g/l

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1.24

0.21

1.5

2.0

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.4

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

2.2

—

2.4

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

481

1.09

0.20

2.6

2.5

2.4

mmol/l

1.24

433

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1.26

0.20

1.5

1.6

—

(3028626) Oxygen [Partial pressure] in Capillary blood

1.25

0.20

1.5

2.7

8.3

kpa

—

(42529406) Shigella sp [Presence] in Stool by Culture

108

1.21

0.20

1.1

1.2

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1.23

0.20

1.3

1.4

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1.23

0.20

1.0

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

212

1.14

0.20

1.5

1.4

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

138

1.17

0.17

2.4

2.0

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

0.74

0.17

1.0

1.1

—

14.5

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.73

0.17

1.0

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

0.71

0.17

1.0

1.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

939

1.06

0.16

3.7

2.5

—

(4094501)

0.76

0.15

1.0

1.1

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

140

1.15

0.15

5.6

3.5

-0.4

1.9

mmol/l

0.80

103

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

367

0.92

0.14

2.0

1.7

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

1.20

0.14

1.2

1.0

3.0

2.1

u/ml

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

105

1.15

0.11

1.1

1.3

—

(3009343) pH of Capillary blood

144

1.12

0.10

6.6

3.5

—

7.4

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

183

1.10

0.10

4.6

3.5

24.5

21.3

0.50

(3000330) Specific gravity of Urine by Test strip

125

1.12

0.10

3.5

2.3

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

507

1.05

0.10

1.8

1.4

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

145

1.11

0.09

6.6

3.5

4.9

5.1

kpa

0.49

136

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1.04

0.09

1.0

1.3

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1.14

0.09

1.6

2.9

33.1

51.6

1.27

(3014148) Varicella zoster virus Ab [Titer] in Serum

1.09

0.09

1.0

1.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

107

1.13

0.08

2.5

1.9

—

(3022313) Gas panel - Capillary blood

108

1.11

0.07

8.2

3.6

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1.11

0.06

1.5

1.3

—

(3022217) INR in Platelet poor plasma by Coagulation assay

266

1.06

0.06

6.0

13.2

1.0

1.2

inr

—

(40768793) Breast Pathology biopsy report

131

0.91

0.05

1.5

1.3

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

129

1.09

0.05

1.3

1.5

—

(1761868) Lipid panel - Serum or Plasma

156

1540

1.02

0.05

2.6

2.4

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

242

0.95

0.05

1.3

1.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

101

1.09

0.04

1.9

1.8

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

109

0.92

0.04

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

112

1.07

0.03

1.3

1.2

—

(4035726)

261

1.04

0.02

2.0

1.3

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

102

1031

0.99

0.02

3.4

3.3

2.4

mmol/l

0.27

940

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

349

0.97

0.02

5.2

4.5

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

288

0.97

0.02

2.0

2.3

68.5

35.2

u/ml

0.42

273

(3019225) pH of Specimen

257

0.97

0.01

7.2

3.9

—

(3042936) Bacteria identified in Isolate by Culture

406

0.98

0.00

2.1

1.8

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

148

1.01

0.00

1.3

152.7

232.9

miu/ml

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

129

1.01

0.00

1.3

1.7

1.1

1.2

g/l

1.19

121

(3010813) Leukocytes [#/volume] in Blood

387

3869

1.01

0.00

20.6

15.8

6.7

6.5

e9/l

1.84

382

3792

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

113

0.97

0.00

23.3

8.7

—

(3027944) Amphetamines [Presence] in Urine

165

1.03

0.00

5.0

1.4

—

(4010399)

225

1.02

0.00

1.4

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1.04

0.00

1.1

2.5

2.3

u/ml

—

(3000492) Spirometry study

365

1.02

0.00

1.3

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

124

0.97

0.00

1.3

1.7

0.2

g/l

1.49

118

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

184

0.98

0.00

1.4

1.8

5.3

2.6

mg/l

—

132

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

0.00

0.0

1.0

—

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

0.00

0.0

1.0

—

(3002619) Bacteria identified in Specimen by Culture

0.00

0.0

1.0

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

0.94

0.00

1.0

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

0.00

0.0

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

0.00

0.0

1.0

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

0.00

0.0

1.0

—

5.9

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.0

1.1

—

(3022689) Creatine [Moles/volume] in Urine

0.00

0.0

1.4

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

0.00

0.0

2.0

—

1.3

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.0

1.0

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(40757373) Influenza virus identified in Isolate

0.00

0.0

1.7

—

(3014271) Vancomycin [Susceptibility]

0.00

0.0

1.9

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.00

0.0

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

0.00

0.0

1.0

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

0.00

0.0

1.0

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

0.00

0.0

3.8

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

0.00

0.0

3.8

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

0.93

0.00

1.3

367.7

454.9

mg/l

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

1.7

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

0.00

0.0

1.0

—

63.3

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

0.00

0.0

1.7

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

0.00

0.0

7.3

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

0.00

0.0

1.0

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

0.00

0.0

2.0

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

0.0

2.8

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

0.00

0.0

1.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.1

—

(3035880) pH of Pleural fluid

0.00

0.0

1.0

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

0.00

0.0

1.3

—

(3013637) Mi-2 Ab [Presence] in Serum

0.00

0.0

1.0

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

1.00

0.00

1.8

3.4

21.2

46.7

u/ml

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.00

0.0

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.00

0.0

1.1

—

(3011436) Histone Ab [Units/volume] in Serum

0.00

0.0

1.1

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: AB1_CHLAMY_OTHER – Diseases caused by chlamydiae

GWS hits: -

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Diseases caused by chlamydiae

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Diseases caused by chlamydiae (AB1_CHLAMY_OTHER)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

LabWAS

Mortality – FinRegistry

Relationships between endpoints